Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

A Common Polymorphism in RNASE6 Impacts Its Antimicrobial Activity Toward Uropathogenic Escherichia coli

Version 1 : Received: 8 November 2023 / Approved: 9 November 2023 / Online: 9 November 2023 (07:22:41 CET)

A peer-reviewed article of this Preprint also exists.

Anguita, R.; Prats-Ejarque, G.; Moussaoui, M.; Becknell, B.; Boix, E. A Common Polymorphism in RNASE6 Impacts Its Antimicrobial Activity toward Uropathogenic Escherichia coli. Int. J. Mol. Sci. 2024, 25, 604. Anguita, R.; Prats-Ejarque, G.; Moussaoui, M.; Becknell, B.; Boix, E. A Common Polymorphism in RNASE6 Impacts Its Antimicrobial Activity toward Uropathogenic Escherichia coli. Int. J. Mol. Sci. 2024, 25, 604.

Abstract

Human Ribonuclease (RNase) 6 is a monocyte and macrophage-derived protein with potent an-timicrobial activity toward uropathogenic bacteria. The RNASE6 gene is heterogeneous in hu-mans due to the presence of single nucleotide polymorphisms (SNPs). RNASE6 rs1045922 is the most common non-synonymous SNP, resulting in a G to A substitution that determines an ar-ginine (R) to glutamine (Q) transversion at position 66 in the protein sequence. By structural analysis we observed that R66Q substitution significantly reduces the positive electrostatic charge at the protein surface. Here, we generated both recombinant RNase 6 -R66 and -Q66 protein variants and determined their antimicrobial activity toward uropathogenic Escherichia coli (UPEC), the most common cause of UTI. We found that the R66 variant, encoded by the major SNP rs1045922 allele, exhibited superior bactericidal activity in comparison to the Q66 variant. The higher bactericidal activity of R66 variant correlated with an increase in the protein lipopolysac-charide binding and bacterial agglutination abilities, while retaining the same enzymatic effi-ciency. These findings encourage further work to evaluate RNASE6 SNP distribution and its impact in UTI susceptibility.

Keywords

RNase; RNase 6; RNase k6; single nucleotide polymorphisms; antimicrobial peptides; urinary tract infections; uropathogenic Escherichia coli

Subject

Biology and Life Sciences, Immunology and Microbiology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.